Salesforce highlights AI deal and analyst support, shares recover from 52-week low
Published on 06/24/2026 at 07:12 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSBy Anna Wagner, Analysts & Consensus desk. Reviewed prior to publication on 2026-06-24, 07:11.
Salesforce (US79466L3024) remains under close watch on the NYSE after a marked sell-off in 2026. The CRM specialist now leans on a series of Buy ratings and an AI-focused acquisition of Fin to support a recovery from its recent 52-week low, according to several analyst commentaries and investor letters.
What analysts are saying on CRM
Citizens analyst Patrick Walravens reiterated a market-outperform, effectively Buy, rating on Salesforce and kept his $315 price target, more than double the recent trading level, as highlighted in a recent analyst note.The Motley Fool summary of the Citizens update This reiterated stance helped Salesforce shares gain a little over 2 percent in a session where many technology peers traded lower on broad market weakness.
Truist reaffirmed its Buy rating on June 15 and set a $280 price target, while Jefferies also maintained a Buy view and argued that the planned acquisition of Fin could accelerate Salesforce's AI adoption, especially in agentic and automation use cases.A Yahoo Finance article citing recent Wall Street views and commentary from Jim Cramer Both houses see scope for revenue and margin improvement if management delivers on its mid-term guidance ranges.
AI acquisition and earnings backdrop
Salesforce plans to acquire AI platform Fin in a deal valued around $3.6 billion, with the aim of strengthening its agentic and workflow automation offerings, according to a recent timeline of company events.A CRM stock overview summarizing key June events The acquisition is intended to deepen the integration of generative AI into Salesforce clouds, a central theme for the group in 2026.
On the earnings side, Salesforce recently reported adjusted earnings of roughly $3.88 per share, supported in part by around $27 billion in stock repurchases, according to the same event summary. An investor letter from Diamond Hill Select Strategy noted that shares had come under pressure as revenue and profit growth trailed earlier expectations, but it still highlighted management's long-term projections for improving growth and profitability if AI investments scale as planned.
All news and analysis on the Salesforce shares
Further figures, commentary and regulatory filings on Salesforce can be found in the ad-hoc-news topic overview and on the company’s investor-relations pages.
How Salesforce earns its money
Salesforce generates most of its revenue from subscription and support fees linked to its flagship Customer 360 cloud, including Sales Cloud, Service Cloud, and Data Cloud, which bundle analytics and AI-based tools into enterprise subscriptions. The company has also expanded its Agentforce and Einstein AI platforms, which recently surpassed an annual recurring revenue mark of over $1 billion, underlining the strategic focus on AI-native services within its broader enterprise software portfolio.
Where the shares trade today
The Salesforce shares (US79466L3024) most recently traded on the NYSE under the ticker CRM at around $153.5 per share, based on late-June indicative pricing data, after touching a 52-week low near $146.3 during the prior session.
Key data on the Salesforce shares
- Company: Salesforce, Inc.
- ISIN: US79466L3024
- WKN: A0B87V
- Ticker: CRM
- Trading venue: NYSE
- Price (as of 2026-06-24, 06:59): 153.55 USD
- Market cap: 120 billion USD (as of 2026-06-24)
- Sector / industry: Information Technology / Application Software
- Index membership: S&P 500
- Next earnings date: not officially scheduled
Disclaimer: This article is for informational purposes only and does not constitute investment advice, investment recommendation or an offer to buy or sell securities. Investors should conduct their own research and, where appropriate, consult a qualified financial adviser before making investment decisions.
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
